Home
The Department of Biomedicine

News archive for The Department of Biomedicine

A new study undertaken at UiB does answer one set of questions, however, raises many more with regards to the potential use of specific VEGF isoforms in order to promote re-vascularisation in heart failure.
We have established a new method to use Positron emission tomography CT (PET CT) to evaluate Glomerular Filtration Rate (GFR) in rats. GFR is a pivotal parameter for kidney function. The traditional method to evaluate GFR is cumbersome with several time-points for blood and urine sampling. Imaging modalities are ideal to evaluate small animal kidney function due to the non-invasive and repeatable... Read more
Our new paper on entangling selectivity determining features and on how to use this knowledge to design selective ligands has been published in J Med Chem!
N-terminal acetylation is a very common protein modification and NAA10 is the major responsible enzyme in human cells. Here we found a novel pathological NAA10 variant, NAA10 p. (R83H), in two boys with developmental delay and intellectual disabilities.
The week-long matrix biology (BMED904) course was held for 4th time at the Dept. of biomedicine and next BMED904 course will be given in June 2021.
The structure of full-length phenylalanine hydroxylase in complex with the cofactor BH4 is presented in the most recent issue of PNAS. As the cofactor is also used as a therapy for PKU, this structure is of medical importance.
Researchers from the lab of Aurora Martinez describe a novel mechanism for the degradation of enzymes involved in phenylketonuria and other neurometabolic disorders.
Cancer is a complex disease caused by a multitude of factors gone wrong in the cell. NAA10 may be one such factor. This is a protein that performs many different tasks, including the most common which is catalyzing the acetylation of cellular proteins. NAA10 can therefore be viewed as a ”Jack of all trades”-protein. For two decades it has been linked to cancer progression, but recent data puts... Read more
Attention-deficit/hyperactivity disorder and autoimmune diseases: etiological relationships and therapeutic possibilities
Suicide gene therapy of glioblastoma induces an immunosuppressive microenvironment.
One long-standing question in myelin biochemistry was solved, as a new binding partner specific for the large isoform of MAG was identified.
Matrix Biology group leader and CCBIO PI Donald Gullberg recently returned from an inspiring conference in China.
The research laboratory for brain cancer immunology and therapy at the Department of Biomedicine has received the secretary general of the Brain-Tumour Society Rolf Ledal to discuss current and future research projects.
This phase IB/II trial is designed to investigate the safety and survival benefits for patients with recurrent glioblastoma with unmethylated MGMT promoter treated with Bortezomib and Temozolomide in a specific schedule.
Meg Veruki and Espen Hartveit from the Retinal Microcircuits Research Group at the Department of Biomedicine have been chosen to be the Visionaries of the Quarter for the European Vision Institute.

Pages